Vaxart Inc (VXRT)
0.7097
+0.05
(+7.79%)
USD |
NASDAQ |
Apr 26, 16:00
0.7095
0.00 (0.00%)
After-Hours: 20:00
Vaxart Max Drawdown (5Y): 99.06% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 99.06% |
February 29, 2024 | 99.06% |
January 31, 2024 | 99.06% |
December 31, 2023 | 99.06% |
November 30, 2023 | 99.06% |
October 31, 2023 | 99.06% |
September 30, 2023 | 99.06% |
August 31, 2023 | 99.06% |
July 31, 2023 | 99.06% |
June 30, 2023 | 99.06% |
May 31, 2023 | 99.06% |
April 30, 2023 | 99.06% |
March 31, 2023 | 99.06% |
February 28, 2023 | 99.06% |
January 31, 2023 | 99.06% |
December 31, 2022 | 99.06% |
November 30, 2022 | 99.23% |
October 31, 2022 | 99.30% |
September 30, 2022 | 99.30% |
August 31, 2022 | 99.30% |
July 31, 2022 | 99.30% |
June 30, 2022 | 99.30% |
May 31, 2022 | 99.30% |
April 30, 2022 | 99.30% |
March 31, 2022 | 99.30% |
Date | Value |
---|---|
February 28, 2022 | 99.30% |
January 31, 2022 | 99.30% |
December 31, 2021 | 99.30% |
November 30, 2021 | 99.30% |
October 31, 2021 | 99.30% |
September 30, 2021 | 99.30% |
August 31, 2021 | 99.30% |
July 31, 2021 | 99.30% |
June 30, 2021 | 99.30% |
May 31, 2021 | 99.30% |
April 30, 2021 | 99.30% |
March 31, 2021 | 99.30% |
February 28, 2021 | 99.30% |
January 31, 2021 | 99.30% |
December 31, 2020 | 99.30% |
November 30, 2020 | 99.30% |
October 31, 2020 | 99.30% |
September 30, 2020 | 99.30% |
August 31, 2020 | 99.30% |
July 31, 2020 | 99.30% |
June 30, 2020 | 99.30% |
May 31, 2020 | 99.30% |
April 30, 2020 | 99.30% |
March 31, 2020 | 99.30% |
February 29, 2020 | 99.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.06%
Minimum
Dec 2022
99.30%
Maximum
Apr 2019
99.24%
Average
99.30%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
Novavax Inc | 98.82% |
aTyr Pharma Inc | 99.44% |
Allogene Therapeutics Inc | 95.78% |
AIM ImmunoTech Inc | 99.76% |
Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -15.38 |
Beta (5Y) | 0.4362 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 218.2% |
Historical Sharpe Ratio (5Y) | -0.0444 |
Historical Sortino (5Y) | -0.2175 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.68% |